RIP1 INHIBITING HETEROCYCLIC COMPOUNDS
VE6142020000208SUndetermined Publication Date: 2022-02-17RIGEL PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- VE · VE
- Patent Type
- Designs
- Current Assignee / Owner
- RIGEL PHARMACEUTICALS INC
- Filing Date
- 2020-11-20
- Publication Date
- 2022-02-17
Need to check novelty before this filing date? Find Prior Art
Description
This document describes kinase inhibitor compounds, such as receptor-interacting protein 1 (RIP1) kinase inhibitors, as well as pharmaceutical compositions and combinations comprising such inhibitor compounds. The compounds may have a structure according to Formula I. This document describes kinase inhibitor compounds, such as receptor-interacting protein 1 (RIP1) kinase inhibitors, as well as pharmaceutical compositions and combinations comprising such inhibitor compounds. COMPOUNDS CAN HAVE A STRUCTURE ACCORDING TO FORMULA I